European Society for Medical Oncology (ESMO) shared on LinkedIn:
“Three days, eight special sessions at ESMO Asia 2026 in Singapore, 4-6 December!
From care delivery and access in APAC to AI in oncology, Head and Neck Cancers in Asia, Lung Cancer in non-smokers and ESMO Pan-Asian Guidelines Adaptation. Be part of the Asian and global oncology community.
Late registration ends 4 November: last chance to save.”
You can also read: Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts
